Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials

Maria Norrby, Daner Li, David A. Hokey, Ingrid Kromann, Søren T. Hoff, Peter Andersen, Adriëtte W. de Visser, Simone A. Joosten, Tom H. Ottenhoff, Jan Andersson, Susanna Brighenti, Timo Vesikari, Lars Lindqvist, Markus Maeurer, Raija Ahmed, Shahnaz Mahdavifar, Sean Bennett, J. Bruce McClain, Barbara M. Shepherd

    Research output: Contribution to journalArticleScientificpeer-review

    24 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1652-1661
    Issue number12
    Publication statusPublished - 2017
    Publication typeA1 Journal article-refereed


    • Tuberculosis
    • clinical trial
    • human
    • immunity
    • safety
    • vaccine

    Publication forum classification

    • Publication forum level 1

    Cite this